IN188917B - - Google Patents

Info

Publication number
IN188917B
IN188917B IN1106MU2000A IN188917B IN 188917 B IN188917 B IN 188917B IN 1106MU2000 A IN1106MU2000 A IN 1106MU2000A IN 188917 B IN188917 B IN 188917B
Authority
IN
India
Prior art keywords
composition
tpgs
propofol
parenteral administration
present
Prior art date
Application number
Other languages
English (en)
Inventor
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Shilpa Sudhakar Kocharekar
Original Assignee
Bharat Surums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Surums & Vaccines Ltd filed Critical Bharat Surums & Vaccines Ltd
Priority to IN1106MU2000 priority Critical patent/IN188917B/en
Priority to DE60106647T priority patent/DE60106647T2/de
Priority to CNB018225349A priority patent/CN1283235C/zh
Priority to US10/250,420 priority patent/US20040235964A1/en
Priority to EP01999369A priority patent/EP1351669B1/en
Priority to MXPA03006054 priority patent/MX228228B/es
Priority to CA002432549A priority patent/CA2432549A1/en
Priority to AT01999369T priority patent/ATE279917T1/de
Priority to AU2002217418A priority patent/AU2002217418A1/en
Priority to ES01999369T priority patent/ES2231583T3/es
Priority to PCT/IN2001/000213 priority patent/WO2002045709A1/en
Priority to RU2003119556/15A priority patent/RU2257892C2/ru
Publication of IN188917B publication Critical patent/IN188917B/en
Priority to ZA200304981A priority patent/ZA200304981B/en
Priority to HK04107880A priority patent/HK1064954A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN1106MU2000 2000-12-07 2000-12-07 IN188917B (sh)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (sh) 2000-12-07 2000-12-07
AT01999369T ATE279917T1 (de) 2000-12-07 2001-12-05 Klare propofolzusammensetzungen
AU2002217418A AU2002217418A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
US10/250,420 US20040235964A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
EP01999369A EP1351669B1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
MXPA03006054 MX228228B (es) 2000-12-07 2001-12-05 Composiciones de propofol claras, estables.
CA002432549A CA2432549A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
DE60106647T DE60106647T2 (de) 2000-12-07 2001-12-05 Klare propofolzusammensetzungen
CNB018225349A CN1283235C (zh) 2000-12-07 2001-12-05 清澈稳定的丙泊酚组合物
ES01999369T ES2231583T3 (es) 2000-12-07 2001-12-05 Composiciones transparentes de propofol.
PCT/IN2001/000213 WO2002045709A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
RU2003119556/15A RU2257892C2 (ru) 2000-12-07 2001-12-05 Прозрачные стабильные композиции пропофола
ZA200304981A ZA200304981B (en) 2000-12-07 2003-06-26 Clear propofol compositions.
HK04107880A HK1064954A1 (en) 2000-12-07 2004-10-13 Clear propofol compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (sh) 2000-12-07 2000-12-07

Publications (1)

Publication Number Publication Date
IN188917B true IN188917B (sh) 2002-11-23

Family

ID=11097320

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1106MU2000 IN188917B (sh) 2000-12-07 2000-12-07

Country Status (14)

Country Link
US (1) US20040235964A1 (sh)
EP (1) EP1351669B1 (sh)
CN (1) CN1283235C (sh)
AT (1) ATE279917T1 (sh)
AU (1) AU2002217418A1 (sh)
CA (1) CA2432549A1 (sh)
DE (1) DE60106647T2 (sh)
ES (1) ES2231583T3 (sh)
HK (1) HK1064954A1 (sh)
IN (1) IN188917B (sh)
MX (1) MX228228B (sh)
RU (1) RU2257892C2 (sh)
WO (1) WO2002045709A1 (sh)
ZA (1) ZA200304981B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
BR0313060A (pt) 2002-07-29 2005-06-28 Transform Pharmaceuticals Inc Composições farmacêuticas aquosas de 2,6-diisopropilfenol
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
EA010242B1 (ru) 2004-02-13 2008-06-30 Биоавейлэбилити, Инк. Препарат микроэмульсии с высокой концентрацией пропофола для анестезирующих применений
EP1799266A2 (en) * 2004-09-13 2007-06-27 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
EP2548456B1 (en) * 2008-03-20 2015-07-08 Virun, Inc. Emulsions including a PEG-derivative of tocopherol
AT514764A1 (de) * 2013-09-02 2015-03-15 Sanochemia Ag Beta-Carotin Zubereitung
US11266621B1 (en) * 2014-10-02 2022-03-08 Exela Sterile Medicines Llc Methocarbamol composition and related methods
AU2016367708B2 (en) * 2015-12-09 2022-07-14 Phosphagenics Limited Pharmaceutical formulation
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법
CN114601800B (zh) * 2021-09-28 2023-07-28 天津瑞普生物技术股份有限公司 一种甲磷丙泊酚钠无菌粉针剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
ES2292233T3 (es) * 1998-02-10 2008-03-01 Sicor Inc. Composicion de propofol que contiene sulfito.
DE69922252T2 (de) * 1999-01-28 2005-12-01 Patel, Dinesh Shantilal Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel
US6743436B1 (en) * 1999-06-21 2004-06-01 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
IN187686B (sh) * 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
DE60106647D1 (de) 2004-11-25
DE60106647T2 (de) 2005-11-10
AU2002217418A1 (en) 2002-06-18
ES2231583T3 (es) 2005-05-16
CA2432549A1 (en) 2002-06-13
CN1489457A (zh) 2004-04-14
RU2257892C2 (ru) 2005-08-10
ATE279917T1 (de) 2004-11-15
CN1283235C (zh) 2006-11-08
MX228228B (es) 2005-06-01
US20040235964A1 (en) 2004-11-25
WO2002045709A1 (en) 2002-06-13
EP1351669B1 (en) 2004-10-20
EP1351669A1 (en) 2003-10-15
MXPA03006054A (es) 2003-09-10
HK1064954A1 (en) 2005-02-08
ZA200304981B (en) 2004-04-23

Similar Documents

Publication Publication Date Title
IN188917B (sh)
AP2002002674A0 (en) Clear Aqueous Anaesthetic composition.
KR960033471A (ko) 나노현탁액용 제약 담체
MXPA05001061A (es) Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol.
IL117889A0 (en) Pharmaceutical compositions containing lipophilic compounds
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
CA2396927A1 (en) Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
BR0111266A (pt) Sìntese reduzida de derivados de 3,3-diarilpropilamina
CA2429639A1 (en) Stable azithromycin monohydrate
US4481187A (en) Clear liquid skin cosmetic compositions
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
JP2007169232A (ja) 眼科用組成物
EP0616800A2 (en) Odorant compositions with prolonged diffusion
GEP20033046B (en) Parenteral Cisplatin Emulsion
JP2003012492A (ja) 化粧料
AU8008401A (en) Amphotericin b structured emulsion
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
US5369092A (en) Odorant compositions
NO173635B (no) Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat
IL153010A0 (en) 3,3-dimethylcyclohexane derivatives
JP3446173B2 (ja) 白濁化粧料
JPS60184003A (ja) 油中水滴型乳化化粧料
HK1057333A1 (en) Flavone-containing plant extract solutions having improved storage and heat stability
AU3193401A (en) Cosmetic compositions comprising a cationic polymer/anionic surfactant mixture and use of said mixture as conditioning agent